Search results
- ETF DAILY NEWS
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Average Rating of “Moderate Buy” from Analysts
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten brokerages that a...
12 hours ago
- The Joplin Globe, Mo. via Yahoo
Allo scouts locations for fiber lines in Joplin
Jul. 16—Joplin's future fiber broadband provider is actively scoping out the city to prepare for construction of the new system. Efforts to ...
4 days ago